Safety and early efficacy data to be presented from clinical trial of Bria-IMT™ in combination with immune checkpoint inhibitors in advanced breast cancer:• Bria-IMT™ in combination with pembrolizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback